Non-motor symptoms (nms) improvement is correlated with baseline nms burden and improved quality of life (QoL) in levodopa-carbidopa intestinal gel (LCIG) treated parkinson’s disease patients

著录项

• 来源
  《Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology》 |2017年第2017期|共1页
• 作者

  K.R. Chaudhuri; W. Poewe; L. Bergmann; A. Yegin; A. Antonini;

  展开▼
• 作者单位

  King’s College and King’s College Hospital Basic and Clinical Neuroscience;

  Medical University of Innsbruck Neurology;

  AbbVie Inc. Global Medical Affairs Neuroscience;

  AbbVie Inc. Global Medical Affairs Neuroscience;

  Parkinson and Movement Disorders Unit- IRCCS Hospital San Camillo Neurosurgery;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 神经病学;
• 关键词